Moderna has been awarded a potential $472M contract modification by the Biomedical Advanced Research and Development Authority to expand late-stage clinical trials of the biotechnology firm’s vaccine candidate for the novel coronavirus....
The Department of Health and Human Services’ bioresearch arm and the Department of Defense have earmarked $1.95B to procure 100M doses of an investigational COVID-19 vaccine Pfizer developed with German pharmaceutical company BioNTech....
The National Institutes of Health is looking for potential offerors of cybersecurity program management support services for its National Center for Advancing Translational Sciences....
Four commercial and nonprofit organizations have won spots on a potential five-year, $90M blanket purchase agreement to conduct social science research for the Food and Drug Administration, FedHealthIT reported Friday....
The departments of Defense and Health and Human Services awarded contracts worth $2.05B combined to biopharmaceutical companies Novavax and Regeneron to accelerate the manufacture of their respective COVID-19 vaccine and treatment candidates....
Bridget Gauer, former director of the National Institutes of Health’s Information Technology Acquisition and Assessment Center, has joined IT consulting firm Cognosante as senior vice president of strategy....
The Biomedical Advanced Research and Development Authority has agreed to give materials engineering company Corning approximately $204M to expand manufacturing capacity for glass vials to store potential vaccines for the novel coronavirus that causes COVID-19....
The Department of Health and Human Services has awarded Gaithersburg, Md.-based biopharmaceutical company Emergent BioSolutions a $628M task order to support the production of potential vaccines for the novel coronavirus through 2021....
AstraZeneca and the Department of Health and Human Services have signed a potential $1.2B public-private partnership agreement to further develop a recombinant adenovirus vaccine as potential treatment for the novel coronavirus....
The Food and Drug Administration is looking to deploy artificial intelligence-based capabilities to support the drug product assessments and business operations....
